1. Home
  2. ANNA vs GNFT Comparison

ANNA vs GNFT Comparison

Compare ANNA & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANNA
  • GNFT
  • Stock Information
  • Founded
  • ANNA 2007
  • GNFT 1999
  • Country
  • ANNA United States
  • GNFT France
  • Employees
  • ANNA N/A
  • GNFT 180
  • Industry
  • ANNA
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ANNA
  • GNFT Health Care
  • Exchange
  • ANNA NYSE
  • GNFT Nasdaq
  • Market Cap
  • ANNA 230.0M
  • GNFT 214.5M
  • IPO Year
  • ANNA N/A
  • GNFT 2019
  • Fundamental
  • Price
  • ANNA $9.70
  • GNFT $4.44
  • Analyst Decision
  • ANNA
  • GNFT Strong Buy
  • Analyst Count
  • ANNA 0
  • GNFT 1
  • Target Price
  • ANNA N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • ANNA 10.6K
  • GNFT 10.0K
  • Earning Date
  • ANNA 05-15-2025
  • GNFT 04-24-2025
  • Dividend Yield
  • ANNA N/A
  • GNFT N/A
  • EPS Growth
  • ANNA N/A
  • GNFT N/A
  • EPS
  • ANNA N/A
  • GNFT 0.03
  • Revenue
  • ANNA $2,064,630.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • ANNA N/A
  • GNFT $15.98
  • Revenue Next Year
  • ANNA N/A
  • GNFT N/A
  • P/E Ratio
  • ANNA N/A
  • GNFT $145.64
  • Revenue Growth
  • ANNA N/A
  • GNFT 105.01
  • 52 Week Low
  • ANNA $4.71
  • GNFT $2.55
  • 52 Week High
  • ANNA $18.70
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • ANNA N/A
  • GNFT 63.99
  • Support Level
  • ANNA N/A
  • GNFT $4.22
  • Resistance Level
  • ANNA N/A
  • GNFT $4.39
  • Average True Range (ATR)
  • ANNA 0.00
  • GNFT 0.20
  • MACD
  • ANNA 0.00
  • GNFT 0.00
  • Stochastic Oscillator
  • ANNA 0.00
  • GNFT 96.18

About ANNA ALEANNA INC

AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: